Clinical Utility of Medication-Based Risk Scores to Reduce Polypharmacy and Potentially Avoidable Healthcare Utilization

MLA

Armando Silva-Almodóvar, and Milap C. Nahata. “Clinical Utility of Medication-Based Risk Scores to Reduce Polypharmacy and Potentially Avoidable Healthcare Utilization.” Pharmaceuticals, vol. 15, no. 6, May 2022, p. 681. EBSCOhost, https://doi.org/10.3390/ph15060681.

APA

Armando Silva-Almodóvar, & Milap C. Nahata. (2022). Clinical Utility of Medication-Based Risk Scores to Reduce Polypharmacy and Potentially Avoidable Healthcare Utilization. Pharmaceuticals, 15(6), 681. https://doi.org/10.3390/ph15060681

Chicago

Armando Silva-Almodóvar, and Milap C. Nahata. 2022. “Clinical Utility of Medication-Based Risk Scores to Reduce Polypharmacy and Potentially Avoidable Healthcare Utilization.” Pharmaceuticals 15 (6): 681. doi:10.3390/ph15060681.